SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug ...
Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms DUBLIN - February 7, 2019 - Medtronic plc (MDT) ...
Merit Medical Systems, Inc. MMSI recently announced that it has received the FDA’s breakthrough device designation for its product, Embosphere Microspheres, for the Genicular Artery Embolization (“GAE ...
Medtronic has received approval of an expanded indication from the FDA for its Pipeline Flex embolization device, for patients with smaller aneurysms found deeper in the brain. The system was ...
The reported proportion of 34% of patients with advanced-stage HCC may be misleading, as 41% had extrahepatic disease and 19% had portal vein invasion. Official guidelines 4-6 concur that ...
The Global Neurovascular Embolization Devices (Neurology) Market report provides a holistic evaluation of the market for the forecast period. The report comprises various segments as well as an ...
Johnson & Johnson has secured an expanded indication from FDA for its TRUFILL n‑BCA Liquid Embolic System for embolization of the middle meningeal artery for the treatment of symptomatic subacute and ...
Tumor embolization is a minimally invasive procedure performed few days prior to a planned surgical removal of a tumor. Certain tumors that occur in the brain, neck and spine usually have a large ...
Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms An estimated 500,000 people throughout the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback